Int. J. Environ. Res. Public Health 2009, 6 223 78. Willemse, B.; Lesman-Leegte, I.; Timens, W.; Postma, D.; ten Hacken, N. High Cessation Rates of Cigarette Smoking in Subjects With and Without COPD. Chest 2005, 128, 3685-3687. 79. Stead, L.F.; Lancaster, T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst. Rev. 2005, 18, CD001007. 80. Lancaster, T.; Stead, L.F. Self-help interventions for smoking cessation. Cochrane Database Syst. Rev. 2005, 20, CD001118. 81. Stead, L.F; Perera, R.; Lancaster, T. Telephone counseling for smoking cessation. Cochrane Database Syst. Rev. 2006, 19, CD002850. 82. Swartz, L.H.; Noell, J.W.; Schroeder, S.W.; Ary, D.V. A randomised control study of a fully automated internet based smoking cessation programme. Tob. Control 2006, 15, 7-12. 83. Strecher, V.J.; Shiffman, S.; West, R. Randomized controlled trial of a webbased computer- tailored smoking cessation program as a supplement to nicotine patch therapy. Addiction 2005, 100, 682-628. 84. Etter, J.F. Internet-based smoking cessation programs. Int. J. Med. Inform. 2006, 75, 110-116. 85. Molyneux, A.; Lewis, S.; Leivers, U.; Anderton, A.; Antoniak, M.; Brackenridge, A.; Nilsson, F.; McNeill, A.; West, R.; Moxham, J.; Britton, J. Clinical trial comparing nicotine replacement therapy (NRT) plus brief counseling, brief counseling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax 2003, 58, 484-488. 86. Simon, J.A.; Carmody, T.P.; Hudes, E.S.; Snyder, E.; Murray, J. Intensive smoking cessation counselling versus minimal counselling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trial. Am. J. Med. 2003, 114, 555-562. 87. Macleod, Z.R.; Charles, M.A.; Arnaldi, V.C.; Adams, I.M. Telephone counselling as an adjunct to nicotine patches in smoking cessation: a randomised controlled trial. Med. J. Aust. 2003, 179, 349-352. 88. Bader, P.; McDonald, P.W.; Selby, P. An Algorithm for Tailoring Pharmacotherapy for Smoking Cessation: Results from a Delphi Panel of International Experts. Tob. Control 2008 13. [Epub ahead of print doi:10.1136/tc.2008.025635. 89. van der Meer, R.M.; Wagena, E.J.; Ostelo, R.W.; Jacobs, J.E.; van Schayck, C.P. Smoking cessation for chronic obstructive pulmonary disease. Database Syst. Rev. 2003, 2, CD002999. 90. Halpin, D.M.G.; Miravitlles, M. Chronic Obstructive Pulmonary Disease. The Disease and Its Burden to Society. Proc. Am. Thorac. Soc. 2006, 3, 619-623. 91. Siu, E.C.; Tyndale, R.F. Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice. J. Pharmacol. Exp. Ther. 2008, 324, 992-999. 92. Schnoll, R.A.; Lerman, C. Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opin. Emerg. Drugs 2006, 11, 429-444. 93. Foulds, J.; Steinberg, M.B.; Williams, J.M.; Ziedonis, D.M. Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev. 2006, 25, 59-71. 94. Maurer, P.; Jennings, G.T.; Willers, J.; Rohner, F.; Lindman, Y.; Roubicek, K.; Renner, W.A.; Müller, P.; Bachmann, M.F. A therapeutic vaccine for nicotine dependence: preclinical efficacy, and phase I safety and immunogenicity. Eur. J. Immunol. 2005, 35, 2031-2040. 95. Berrettini, W.H.; Lerman, C.E. Pharmacotherapy and pharmacogenetics of nicotine dependence. Am. J. Psychiatry 2005, 162, 1441-1451.